Close Mobile Navigation

WELCOME TO THE
KEYTRUDA
PATIENT SUPPORT
WEBSITE


GET ACCESS

To access this website, you must be a current patient being treated with KEYTRUDA in Australia and be 18 years or older.

  • The access code is supplied within the KEYTRUDA patient booklet which you can request from your healthcare professional, if you don’t have a copy.
  • Alternatively, please contact your treating healthcare professional to request the access code to access this website.

Registered users are no longer required to sign in using their registered email address and password. Please enter the access code to continue accessing this website.

The access code entered is not valid, please try again or contact your Healthcare Professional.


MSD Medical Information or to report product complaints (including adverse events): 1800 818 553

This educational website is sponsored by Merck Sharp & Dohme (Australia) Pty Ltd. Information displayed on this website is only intended for Australian residents who are 18 years or older and are currently being treated with KEYTRUDA and as such, its contents have been designed to comply with Australian laws and regulations. The information on this website is educational only and is not intended to be used for any self-diagnosis purposes nor to replace the advice of your Doctor or healthcare professional. Please consult your Doctor or healthcare professional for further information on KEYTRUDA. Use and access of this website is subject to the terms and conditions set out in our Legal Agreement and Privacy Policy.

Copyright © 2024 Merck & Co., Inc., Rahway, NJ, USA and its affiliates. All rights reserved.
Merck Sharp & Dohme (Australia) Pty Limited. Level 1 – Building A, 26 Talavera Road, Macquarie Park NSW 2113.
AU-KEY-00559. Issued March 2024.


JUST BEEN PRESCRIBED KEYTRUDA

As you start on your KEYTRUDA treatment, you are probably feeling a mix of emotions. Confused, anxious, angry, hopeful. These are all common reactions to a diagnosis of cancer. This site is here to help you in many different ways. So take the time to have a look around.


Learn more about KEYTRUDA


What is Immunotherapy?

Immunotherapy is a type of cancer treatment designed to work with the body’s natural defences to treat the cancer.



How is KEYTRUDA given?

KEYTRUDA is given as an infusion. An infusion is when medicine is delivered via needle or catheter directly into a vein.



How does KEYTRUDA work?

KEYTRUDA works by helping your immune system fight your cancer.





Resources

Download resources that can help you on your treatment journey.



For further information about your condition or treatment consult your healthcare professional or refer to the Consumer Medicine Information for KEYTRUDA.





References

Cancer Council Australia. 2021. Understanding Immunotherapy, A guide for people affected by cancer. Available at: www.cancer.org.au/assets/pdf/understanding-immunotherapy-fact-sheet. Accessed September 2022.

KEYTRUDA Australian Consumer Medicine Information, www.msdinfo.com.au/keytrudacmi.

AU-KEY-00494 (v3.0). Issued October 2024.



MSD Medical Information or to report product complaints (including adverse events): 1800 818 553

This educational website is sponsored by Merck Sharp & Dohme (Australia) Pty Ltd. Information displayed on this website is only intended for Australian residents who are 18 years or older and are currently being treated with KEYTRUDA and as such, its contents have been designed to comply with Australian laws and regulations. The information on this website is educational only and is not intended to be used for any self-diagnosis purposes nor to replace the advice of your Doctor or healthcare professional. Please consult your Doctor or healthcare professional for further information on KEYTRUDA. Use and access of this website is subject to the terms and conditions set out in our Legal Agreement and Privacy Policy.

Copyright © 2024 Merck & Co., Inc., Rahway, NJ, USA and its affiliates. All rights reserved.
Merck Sharp & Dohme (Australia) Pty Limited. Level 1 – Building A, 26 Talavera Road, Macquarie Park NSW 2113.
AU-KEY-00559. Issued March 2024.